| Prescription ID | TCMF6619 |
| Pinyin Name | Yi Shen Ling Wan |
| Chinese Name | 益身çµä¸¸ |
| English Name | Yi Shen Ling Pills |
| Function Description | 眩晕, å¥å¿˜, ä¸å¯, é—ç²¾, 阳痿 |
| Indications | Involuntary ejaculation disorder, Impotence disorder, Vertigo disorder, Forgetfulness disorder, Insomnia disorder, Insomnia, Dizziness, Sexual dysfunction |
| Disease ICD-11 Category |
SB09 [Involuntary ejaculation disorder (TM1), é—ç²¾ (TM1)
]; SB0B [Impotence disorder (TM1), 阳痿 (TM1) ]; SD22 [Vertigo disorder (TM1), 眩晕 (TM1) ]; SD23 [Forgetfulness disorder (TM1), å¥å¿˜ (TM1) ]; SD84 [Insomnia disorder (TM1), ä¸å¯ (TM1) ]; 7A0Z [Insomnia disorders, unspecified, å¤±çœ éšœç¢ï¼Œæœªç‰¹æŒ‡çš„ ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; HA0Z [Sexual dysfunctions, unspecified, 性功能障ç¢ï¼Œæœªç‰¹æŒ‡çš„ ]; |
| Human Tissues Associated with Indication | Brain, Heart, Kidney |
| Reference | CFDA |
| Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
| Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
|---|---|---|---|---|
| TCMH426 | Codonopsis pilosula | å…šå‚ | TCMH426 | ITSAL4530-14 |
| TCMH1349 | Cervus elaphus | 鹿茸 | TCMH1349 | ABMC060-05 |
| TCMH193 | Psoralea corylifolia | 补骨脂 | TCMH193 | |
| TCMH1186 | Lycium chinense | 枸æžå | TCMH1186 | ITSAO4545-14 |
| TCMH421 | Angelica sinensis | 当归 | TCMH421 | ITSAF173-14 |
| TCMH1423 | Ophiopogon japonicus | 麦冬 | TCMH1423 | ITSAJ4140-14 |
| TCMH121 | Biota orientalis | æŸåä» | TCMH121 | |
| TCMH120 | Atractylodes macrocephala | 白术 | TCMH120 | ITSAN4430-14 |
| TCMH243 | Pericarpium citri reticulatae | 陈皮 | TCMH243 | |
| TCMH517 | Angelica pubescens | 独活 | TCMH517 | ITSAF170-14 |
| TCMH628 | Glycyrrhiza uralensis | ç”˜è‰ | TCMH628 | ITSAM892-14 |
| TCMH2149 | Cuscuta australis | èŸä¸å | TCMH2149 | ITSAP4209-14 |
| TCMH1966 | Rehmannia glutinosa | 熟地黄 | TCMH1966 | ITSAH4578-14 |
| TCMH2202 | Schisandra chinensis | 五味å | TCMH2202 | ITSAM2867-14 |
| TCMH2554 | Polygala tenuifolia | 远志 | TCMH2554 | MF096619 |
| TCMH2052 | Ziziphus jujuba var. spinosa | é…¸æž£ä» | TCMH2052 | ITSAM943-14 |
| TCMH1845 | Dioscorea batatas | å±±è¯ | TCMH1845 |
| Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
|---|---|---|---|---|
| TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
| TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
| TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
| TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
| TCMT128 | TNKS2 | Tankyrase-2 | Transferase | Q9H2K2 |
| TCMT129 | TNKS | Tankyrase-1 | Transferase | O95271 |
| TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
| TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
| TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
| TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
| TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
| TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
| TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
| TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
| TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
| TCMT139 | CA6 | Carbonic anhydrase VI | Lyase | P23280 |
| TCMT140 | CA5B | Carbonic anhydrase VB | Lyase | Q9Y2D0 |
| TCMT141 | CA5A | Carbonic anhydrase VA | Lyase | P35218 |
| TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
| TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
| TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
| TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
| TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
| TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
| TCMT189 | DUSP3 | Dual specificity protein phosphatase 3 | Hydrolase | P51452 |
| TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
| TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
| TCMT206 | CYP2A6 | Cytochrome P450 2A6 | Oxidoreductase | P11509 |
| TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
| TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
| TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
| TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
| TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
| TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
| TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
| TCMT231 | GBA2 | Beta-glucosidase | Hydrolase | Q9HCG7 |
| TCMT236 | ESR2 | Estrogen receptor beta | Nuclear receptor | Q92731 |
| TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
| TCMT249 | CDK6 | Cyclin-dependent kinase 6 | Kinase | Q00534 |
| TCMT254 | CBR1 | Carbonyl reductase [NADPH] 1 | Oxidoreductase | P16152 |
| TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
| TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
| TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
| TCMT268 | CYP2A13 | Cytochrome P450 2A13 | Oxidoreductase | Q16696 |
| TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
| TCMT290 | CHRM5 | Muscarinic acetylcholine receptor M5 | GPCR | P08912 |
| TCMT291 | CHRM3 | Muscarinic acetylcholine receptor M3 | GPCR | P20309 |
| TCMT292 | CHRM1 | Muscarinic acetylcholine receptor M1 | GPCR | P11229 |
| TCMT293 | CHRM2 | Muscarinic acetylcholine receptor M2 | GPCR | P08172 |
| TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
| TCMT296 | ADORA1 | Adenosine A1 receptor | GPCR | P30542 |
| TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
| TCMT298 | FABP3 | Fatty acid binding protein muscle | Hydrolase | P05413 |
| TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
| TCMT302 | HMGCR | HMG-CoA reductase | Oxidoreductase | P04035 |
| TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
| TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
| TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
| TCMT327 | TRPV1 | Vanilloid receptor | Ion channel | Q8NER1 |
| TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
| TCMT337 | XPO1 | Exportin-1 | Unclassified | O14980 |
| TCMT344 | AOX1 | Aldehyde oxidase | Oxidoreductase | Q06278 |
| TCMT354 | AURKA | Serine/threonine-protein kinase Aurora-A | Kinase | O14965 |
| TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
| TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
| TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
| TCMT377 | INSR | Insulin receptor | Kinase | P06213 |
| TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
| TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
| TCMT418 | EPHB4 | Ephrin type-B receptor 4 | Kinase | P54760 |
| TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
| TCMT423 | EGFR | Epidermal growth factor receptor erbB1 | Kinase | P00533 |
| TCMT436 | NUAK1 | NUAK family SNF1-like kinase 1 | Kinase | O60285 |
| TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
| TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
| TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
| TCMT457 | FLT4 | Vascular endothelial growth factor receptor 3 | Kinase | P35916 |
| TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
| TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
| TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
| TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
| TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
| TCMT502 | TEK | Tyrosine-protein kinase TIE-2 | Kinase | Q02763 |
| TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
| TCMT536 | PDGFRB | Platelet-derived growth factor receptor beta | Kinase | P09619 |
| TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
| TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
| TCMT591 | ESRRA | Estrogen-related receptor alpha | Nuclear receptor | P11474 |
| TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
| TCMT597 | SLC28A3 | Solute carrier family 28 member 3 | Transporter | Q9HAS3 |
| TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
| TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
| TCMT614 | EGLN1 | Egl nine homolog 1 | Oxidoreductase | Q9GZT9 |
| TCMT619 | HSP90AA1 | Heat shock protein HSP 90-alpha | Unclassified | P07900 |
| TCMT624 | HSP90AB1 | Heat shock protein HSP 90-beta | Unclassified | P08238 |
| TCMT626 | BRAF | Serine/threonine-protein kinase B-raf | Kinase | P15056 |
| TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
| TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
| TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
| TCMT666 | VCP | Transitional endoplasmic reticulum ATPase | Transporter | P55072 |
| TCMT67 | PPARG | Peroxisome proliferator-activated receptor gamma | Nuclear receptor | P37231 |
| TCMT689 | TGM2 | Protein-glutamine gamma-glutamyltransferase | Transferase | P21980 |
| TCMT690 | HDAC3 | Histone deacetylase 3 | Hydrolase | O15379 |
| TCMT709 | SLC28A2 | Sodium/nucleoside cotransporter 2 | Transporter | O43868 |
| TCMT710 | SLC28A1 | Sodium/nucleoside cotransporter 1 | Transporter | O00337 |
| TCMT721 | HSPA1A | Heat shock 70 kDa protein 1 | Unclassified | P0DMV8 |
| TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
| TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
| TCMT739 | GPR35 | G-protein coupled receptor 35 | GPCR | Q9HC97 |
| TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
| TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
| TCMT753 | SMAD3 | Mothers against decapentaplegic homolog 3 | Unclassified | P84022 |
| TCMT755 | PLK4 | Serine/threonine-protein kinase PLK4 | Kinase | O00444 |
| TCMT756 | MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Kinase | P41279 |
| TCMT771 | ATR | Serine-protein kinase ATR | Kinase | Q13535 |
| TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
| TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
| TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
| TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
| TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
| TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
| TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
| TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
| TCMT81 | ALOX12 | Arachidonate 12-lipoxygenase | Oxidoreductase | P18054 |
| TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
| TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
| TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
| TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
| TCMT87 | CYP2C9 | Cytochrome P450 2C9 | Oxidoreductase | P11712 |
| TCMT910 | ESRRB | Estrogen-related receptor beta | Nuclear receptor | O95718 |
| Target ID | Target Name |
|---|---|
| TCMT1170 | Enterobacter cloacae |
| TCMT1175 | Human immunodeficiency virus |
| TCMT1176 | Streptococcus pneumoniae |
| TCMT1178 | Actinomyces viscosus |
| TCMT1179 | Escherichia coli ATCC 8739 |
| TCMT1180 | Human herpesvirus 2 |
| TCMT1181 | Mycobacterium tuberculosis H37Ra |
| TCMT1182 | Streptococcus sanguinis |
| TCMT1186 | Plasmodium yoelii yoelii |
| TCMT1189 | Pseudomonas fluorescens |
| TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
| TCMT1191 | Bacillus megaterium |
| TCMT1208 | Escherichia coli K12 |
| TCMT1209 | Staphylococcus haemolyticus |
| TCMT1210 | Streptococcus sobrinus |
| TCMT1211 | Fusobacterium nucleatum |
| TCMT1212 | Verticillium dahliae |
| TCMT1213 | Neisseria gonorrhoeae |
| TCMT1214 | Enterococcus faecium |
| TCMT1215 | Pseudomonas aeruginosa PAO1 |
| TCMT1217 | Bacillus anthracis |
| TCMT1218 | Staphylococcus aureus |
| TCMT1221 | Human herpesvirus 4 |
| TCMT1222 | Plasmodium falciparum D6 |
| TCMT1223 | Staphylococcus epidermidis |
| TCMT1224 | Proteus mirabilis |
| TCMT1226 | Klebsiella pneumoniae |
| TCMT1227 | Streptococcus |
| TCMT1229 | Enterococcus faecalis |
| TCMT1232 | Pseudomonas aeruginosa |
| TCMT1234 | Bacillus coagulans |
| TCMT1235 | Clostridium sporogenes |
| TCMT1236 | Mycobacterium bovis |
| TCMT1237 | Mycobacterium kansasii |
| TCMT1238 | Mycobacterium xenopi |
| TCMT1239 | Mycobacterium marinum |
| TCMT1243 | Aspergillus flavus |
| TCMT1245 | Phytophthora cactorum |
| TCMT1246 | Escherichia coli |
| TCMT1247 | Human herpesvirus 1 |
| TCMT1248 | Hepatitis C virus |
| TCMT1249 | Dengue virus 2 |
| TCMT1250 | Vesicular stomatitis virus |
| TCMT1251 | Candida albicans |
| TCMT1253 | Penicillium chrysogenum |
| TCMT1255 | Human immunodeficiency virus 1 |
| TCMT1260 | Streptococcus agalactiae |
| TCMT1282 | Colletotrichum orbiculare |
| TCMT1284 | Penicillium expansum |
| TCMT1286 | Bacillus cereus |
| TCMT1294 | Human parainfluenza virus 3 |
| TCMT1318 | Human T-lymphotropic virus 1 |
| TCMT1319 | Corynebacterium xerosis |
| TCMT1321 | Staphylococcus hominis |
| TCMT1322 | Streptococcus mitis |
| TCMT1323 | Corynebacterium pseudodiphtheriticum |
| TCMT1324 | Corynebacterium diphtheriae |
| TCMT1343 | Staphylococcus simulans |
| TCMT1344 | Staphylococcus sciuri |
| TCMT1346 | Helicobacter pylori |
| TCMT1349 | Helicobacter pylori SS1 |
| TCMT1361 | Neisseria meningitidis |
| TCMT1370 | Prevotella melaninogenica |
| TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
| TCMT1393 | Vibrio sp. |
| TCMT1408 | Colletotrichum gloeosporioides |
| TCMT1410 | Listeria monocytogenes |
| TCMT1412 | Salmonella typhimurium |
| TCMT1438 | Plasmodium falciparum |
| TCMT1439 | Mycobacterium smegmatis |
| TCMT1442 | Leishmania donovani |
| TCMT1443 | Leishmania amazonensis |
| TCMT1444 | Fusarium oxysporum |
| TCMT1447 | Respiratory syncytial virus |
| TCMT1448 | Enterobacter aerogenes |
| TCMT1449 | Influenza A virus |
| TCMT1450 | Plasmodium falciparum 3D7 |
| TCMT1454 | Bacillus subtilis |
| TCMT1455 | Mycobacterium tuberculosis H37Rv |
| TCMT1457 | Leishmania major |
| TCMT1458 | Filobasidiella neoformans |
| TCMT1462 | Streptococcus mutans |
| TCMT1463 | Mycobacterium tuberculosis |
| TCMT1464 | Hepatitis B virus |
| TCMT1465 | Entamoeba histolytica |
| GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|---|
| [BP] GO:0008152 | metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 13.1335 |
| [BP] GO:0006629 | lipid metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA, PPARG, TRPV1 | 12.9396 |
| [BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, PPARG, SMAD3, SRC, TEK, TRPV1, TYR | 11.6743 |
| [BP] GO:0065008 | regulation of biological quality | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, INSR, KDR, MET, PPARA, PPARG, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1, XDH | 11.6564 |
| [BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, HSP90AB1, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, PPARG, SRC, TEK, TRPV1, TYR | 11.4486 |
| [BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, GBA2, GLO1, HMGCR, HSPA1A, PIM1, PPARA, PPARG, TYR, XDH | 11.357 |
| [BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 11.111 |
| [BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 10.6048 |
| [BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.2266 |
| [BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 9.88101 |
| [BP] GO:0048522 | positive regulation of cellular process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, HCAR2, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 9.8485 |
| [BP] GO:0042221 | response to chemical | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, PPARG, SMAD3, SRC, TEK, TRPV1, TYR | 9.82348 |
| [BP] GO:0043067 | regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH | 9.77157 |
| [BP] GO:0042127 | regulation of cell proliferation | ADORA1, ADORA3, AKR1B1, ALOX12, APP, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARG, SMAD3, SRC, TEK, XDH | 9.76864 |
| [BP] GO:0010941 | regulation of cell death | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH | 9.75247 |
| [BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, INSR, MMP2, NR3C1, PPARA, PPARG, SMAD3, SRC, TEK, TRPV1 | 9.27084 |
| [BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, HSP90AB1, NR3C1, PPARG, SRC, TEK, TRPV1, TYR | 9.27084 |
| [BP] GO:0042981 | regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MMP9, PIM1, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH | 9.17449 |
| [BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, INSR, NR3C1, PPARA, PPARG, SRC, TEK, TRPV1 | 9.16866 |
| [BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR | 9.04493 |
| [BP] GO:0048518 | positive regulation of biological process | ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 9.04493 |
| [BP] GO:0010647 | positive regulation of cell communication | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 9.03127 |
| [BP] GO:0023056 | positive regulation of signaling | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 9.01088 |
| [BP] GO:0044238 | primary metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 8.63175 |
| [BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARG, TYR, XDH | 8.51441 |
| [BP] GO:0032502 | developmental process | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD17B2, HSP90AB1, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, PPARG, SMAD3, SRC, TEK, TNKS2, TOP2A, TYR | 8.19806 |
| [BP] GO:0033993 | response to lipid | ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, PPARG, SRC, TYR | 7.68066 |
| [BP] GO:0071704 | organic substance metabolic process | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 7.53752 |
| [BP] GO:0019369 | arachidonic acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 7.30657 |
| [BP] GO:0032879 | regulation of localization | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1B1, EGFR, F3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TRPV1 | 7.24262 |
| [BP] GO:0060548 | negative regulation of cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK | 7.23876 |
| [BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARG, SMAD3, SRC, TRPV1 | 7.20728 |
| [BP] GO:0043069 | negative regulation of programmed cell death | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 7.15472 |
| [BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, PPARA, PPARG | 7.15472 |
| [BP] GO:0009967 | positive regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GPR35, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 7.04643 |
| [BP] GO:0048513 | animal organ development | ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSP90AB1, INSR, KDR, PPARA, PPARG, SMAD3, SRC, TEK, TYR | 7.01787 |
| [BP] GO:0040012 | regulation of locomotion | ADORA1, ADORA3, ALOX12, APEX1, APP, BCL2, CDK6, CHRM1, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PPARG, SMAD3, SRC, TEK | 6.98727 |
| [BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, INSR, KDR, MMP2, NR3C1, PPARG, SMAD3, SRC, TRPV1 | 6.82362 |
| [BP] GO:2000145 | regulation of cell motility | ADORA1, ADORA3, ALOX12, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PPARG, SMAD3, SRC, TEK | 6.77801 |
| [BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.73487 |
| [BP] GO:0080134 | regulation of response to stress | ADORA1, ALOX12, APP, CDK6, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 6.7031 |
| [BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.64364 |
| [BP] GO:0043066 | negative regulation of apoptotic process | ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK | 6.54353 |
| [BP] GO:0006690 | icosanoid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 6.51399 |
| [BP] GO:0032501 | multicellular organismal process | ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SMAD3, SRC, TEK, TNKS2, TRPV1, TYR | 6.47028 |
| [BP] GO:0030334 | regulation of cell migration | ADORA1, ADORA3, ALOX12, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PPARG, SMAD3, SRC, TEK | 6.47028 |
| [BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, TEK | 6.31299 |
| [BP] GO:0048584 | positive regulation of response to stimulus | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.29674 |
| [BP] GO:0051270 | regulation of cellular component movement | ADORA1, ADORA3, ALOX12, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, PPARG, SMAD3, SRC, TEK | 6.25074 |
| [BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC | 6.24875 |
| [BP] GO:0007197 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.24591 |
| [BP] GO:0048856 | anatomical structure development | ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSP90AB1, INSR, KDR, MMP9, PIM1, PPARA, PPARG, SMAD3, SRC, TEK, TYR | 6.23314 |
| [BP] GO:0010646 | regulation of cell communication | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.22056 |
| [BP] GO:0009628 | response to abiotic stimulus | ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, HMGCR, HSD11B2, HSP90AA1, HSP90AB1, HSPA1A, MMP2, PPARA, PPARG, SMAD3, SRC, TEK, TRPV1, TYR | 6.20912 |
| [BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 6.16689 |
| [BP] GO:0023051 | regulation of signaling | ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 6.08941 |
| [BP] GO:0042493 | response to drug | AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, HSD11B2, HSP90AB1, KDR, NR3C1, PPARG, SRC, TRPV1 | 6.04358 |
| [BP] GO:0050896 | response to stimulus | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR | 6.02814 |
| [BP] GO:0042592 | homeostatic process | ADORA1, AKR1B1, ALOX12, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HSP90AA1, HSP90AB1, INSR, MET, PPARG, SMAD3, SRC, TRPV1 | 6.02814 |
| [BP] GO:0015711 | organic anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, TRPV1 | 5.92942 |
| [BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, SRC, TRPV1 | 5.88878 |
| [BP] GO:0051239 | regulation of multicellular organismal process | ADORA1, ADORA3, ALOX12, APP, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP12, MMP9, PIM1, PPARG, SMAD3, SRC, TEK, TNKS2, TRPV1, XDH | 5.88878 |
| [BP] GO:0007207 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 5.85458 |
| [BP] GO:0010817 | regulation of hormone levels | ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.78569 |
| [BP] GO:0031325 | positive regulation of cellular metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.78569 |
| [BP] GO:0006631 | fatty acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG | 5.73307 |
| [BP] GO:1902533 | positive regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH | 5.72845 |
| [BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PPARG, PTPN1, SMAD3, SRC, TOP2A, TRPV1 | 5.65862 |
| [BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.64778 |
| [BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, SRC, TEK | 5.63957 |
| [BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.62996 |
| [BP] GO:0048583 | regulation of response to stimulus | ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 5.61572 |
| [BP] GO:1902531 | regulation of intracellular signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 5.61572 |
| [BP] GO:0018212 | peptidyl-tyrosine modification | AXL, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, SRC, TEK | 5.59076 |
| [BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSP90AA1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, XDH | 5.57078 |
| [BP] GO:0009893 | positive regulation of metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.52725 |
| [BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.51367 |
| [BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK | 5.46524 |
| [BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 5.38564 |
| [BP] GO:0032844 | regulation of homeostatic process | ADORA1, AURKB, BCL2, CA2, CA7, CDK6, EGFR, HCAR2, HMGCR, KDR, SRC, TNKS, TNKS2, TRPV1 | 5.35305 |
| [BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS | 5.3347 |
| [BP] GO:0032787 | None | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, PPARA, PPARG | 5.31547 |
| [BP] GO:1904407 | positive regulation of nitric oxide metabolic process | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 5.29803 |
| [BP] GO:0045429 | positive regulation of nitric oxide biosynthetic process | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 5.29803 |
| [BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.2812 |
| [BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, HSP90AA1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 5.27378 |
| [BP] GO:0010604 | positive regulation of macromolecule metabolic process | ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, XDH | 5.26114 |
| [BP] GO:1901568 | fatty acid derivative metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.25507 |
| [BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 | 5.25507 |
| [BP] GO:0007346 | regulation of mitotic cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, DUSP3, EGFR, HSP90AA1, HSPA1A, INSR, PIM1, SMAD3, TNKS, TOP2A | 5.25507 |
| [BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, FLT3, HMGCR, HSP90AA1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, XDH | 5.2092 |
| [BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX12, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, GBA2, HMGCR, TYR | 5.19717 |
| [BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, HSD11B2, HSP90AB1, IGF1R, INSR, MMP2, PPARA, PPARG, SRC, TEK, TRPV1, TYR | 5.19717 |
| [BP] GO:1901652 | response to peptide | AKR1B1, APEX1, APP, FABP3, HSD11B2, IGF1R, INSR, PPARA, PPARG, SRC, TEK, TRPV1 | 5.09038 |
| [BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CDK6, CYP1B1, EGFR, HSP90AB1, KDR, NR3C1, SRC, TRPV1 | 5.06841 |
| [BP] GO:2000377 | regulation of reactive oxygen species metabolic process | BCL2, CYP1B1, EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1, XDH | 4.97225 |
| [BP] GO:0030335 | positive regulation of cell migration | ALOX12, APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 4.89784 |
| [BP] GO:0051972 | regulation of telomerase activity | AURKB, HSP90AA1, HSP90AB1, PPARG, SRC, TNKS | 4.89225 |
| [BP] GO:0030522 | intracellular receptor signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, PPARG, SRC | 4.86188 |
| [BP] GO:0019220 | regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CHRM5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.8612 |
| [BP] GO:0048585 | negative regulation of response to stimulus | ADORA1, ALOX12, ALOX15, BCL2, CDK6, CYP19A1, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 4.8453 |
| [BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 4.84058 |
| [BP] GO:0051174 | regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CHRM5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH | 4.80321 |
| [BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, APP, EGFR, FABP3, FLT3, HSD11B2, HSP90AB1, IGF1R, INSR, MMP2, PPARA, PPARG, SRC, TEK, TRPV1, TYR | 4.78144 |
| [BP] GO:1903428 | positive regulation of reactive oxygen species biosynthetic process | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 4.7622 |
| [BP] GO:2000147 | positive regulation of cell motility | ALOX12, APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 4.76049 |
| [BP] GO:0043401 | steroid hormone mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, SRC | 4.75679 |
| [BP] GO:0006820 | anion transport | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, TRPV1 | 4.74194 |
| [BP] GO:0009966 | regulation of signal transduction | ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HMGCR, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH | 4.71333 |
| [BP] GO:2000379 | positive regulation of reactive oxygen species metabolic process | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1, XDH | 4.6564 |
| [BP] GO:0051272 | positive regulation of cellular component movement | ALOX12, APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 4.63859 |
| [BP] GO:0051240 | positive regulation of multicellular organismal process | ALOX12, APP, AXL, BCL2, CA2, CHRM3, CYP1B1, EGFR, ESRRB, F3, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP12, MMP9, PIM1, PPARG, SMAD3, SRC, TEK, TRPV1 | 4.63859 |
| [BP] GO:0008283 | cell proliferation | ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK, TYR | 4.58937 |
| [BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, APP, AXL, CDK6, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 | 4.57074 |
| [BP] GO:0045428 | regulation of nitric oxide biosynthetic process | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 4.55693 |
| [BP] GO:0007165 | signal transduction | ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1 | 4.49039 |
| [BP] GO:0040017 | positive regulation of locomotion | ALOX12, APP, BCL2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK | 4.4874 |
| [BP] GO:0010562 | positive regulation of phosphorus metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, HMGCR, HSP90AB1, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 4.39405 |
| [BP] GO:0045937 | positive regulation of phosphate metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FABP3, FLT3, HMGCR, HSP90AB1, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH | 4.39405 |
| [BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK | 4.3852 |
| [BP] GO:0051049 | regulation of transport | ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, EGFR, GPR35, HCAR2, HMGCR, HSP90AB1, HSPA1A, INSR, MMP12, MMP9, PPARA, PPARG, PTPN1, SMAD3, SRC, TRPV1 | 4.3839 |
| [BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.34306 |
| [BP] GO:0051098 | regulation of binding | APP, AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, SMAD3, SRC, TNKS | 4.33053 |
| [BP] GO:0050790 | regulation of catalytic activity | ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 4.31237 |
| [BP] GO:0065009 | regulation of molecular function | ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TRPV1, XDH | 4.3063 |
| [BP] GO:2000573 | positive regulation of DNA biosynthetic process | AURKB, HSP90AA1, HSP90AB1, SRC, TNKS, TNKS2 | 4.28756 |
| [BP] GO:0051338 | regulation of transferase activity | ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, INSR, PPARG, PTPN1, SRC, TEK, TNKS | 4.25656 |
| [BP] GO:2000278 | regulation of DNA biosynthetic process | AURKB, HSP90AA1, HSP90AB1, PPARG, SRC, TNKS, TNKS2 | 4.25613 |
| [BP] GO:0051054 | positive regulation of DNA metabolic process | AURKB, EGFR, HSP90AA1, HSP90AB1, IGF1R, INSR, SRC, TNKS, TNKS2 | 4.24524 |
| [BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC | 4.18024 |
| [BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TNKS | 4.13165 |
| [BP] GO:0019216 | regulation of lipid metabolic process | ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, PPARA, PPARG, SRC, TEK | 4.11528 |
| [BP] GO:0007213 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 4.10147 |
| [BP] GO:0070482 | response to oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PPARG, SMAD3, SRC, TEK | 4.08652 |
| [BP] GO:0051726 | regulation of cell cycle | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DUSP3, EGFR, HSP90AA1, HSP90AB1, HSPA1A, INSR, PIM1, SMAD3, SRC, TNKS, TOP2A | 4.06728 |
| [BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, PTPN1, SRC, TNKS | 4.06728 |
| [BP] GO:0009891 | positive regulation of biosynthetic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, PPARG, SMAD3, SRC, TNKS, TNKS2, TOP2A, TRPV1 | 4.05088 |
| [BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AURKB, AXL, BCL2, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PPARG, SMAD3, SRC, TEK, TNKS, TNKS2 | 4.04499 |
| [BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK | 4.04499 |
| [BP] GO:0048878 | chemical homeostasis | AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, PPARG, SMAD3, TRPV1 | 4.03945 |
| [BP] GO:0009755 | hormone-mediated signaling pathway | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG, SRC | 4.03175 |
| [BP] GO:0009056 | catabolic process | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GBA2, HSP90AA1, HSPA1A, MMP1, MMP12, MMP2, MMP9, SRC, XDH | 3.95535 |
| [BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.94704 |
| [BP] GO:0009987 | cellular process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HCAR2, HMGCR, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 3.94602 |
| [BP] GO:0051050 | positive regulation of transport | ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, EGFR, HCAR2, HSP90AB1, INSR, MMP12, PPARG, SMAD3, SRC, TRPV1 | 3.93208 |
| [BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC | 3.91087 |
| [BP] GO:0019752 | carboxylic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, PIM1, PPARA, PPARG, TYR | 3.90686 |
| [BP] GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TOP2A | 3.86952 |
| [BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, PPARA, SMAD3 | 3.82724 |
| [BP] GO:0006720 | isoprenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, HMGCR | 3.80455 |
| [BP] GO:0007166 | cell surface receptor signaling pathway | ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1 | 3.79414 |
| [BP] GO:0042327 | positive regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ESRRB, FLT3, HMGCR, HSP90AB1, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.79414 |
| [BP] GO:0044093 | positive regulation of molecular function | ADORA1, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, HSP90AA1, HSP90AB1, HSPA1A, INSR, MET, MMP9, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 3.78117 |
| [BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK | 3.76726 |
| [BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, HSP90AB1, INSR, MMP2, MMP9, PPARG, SRC, TOP2A | 3.75958 |
| [BP] GO:0051247 | positive regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MMP9, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 3.74659 |
| [BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, HMGCR, HSP90AA1, KDR, SRC | 3.74659 |
| [BP] GO:2001300 | lipoxin metabolic process | ALOX12, ALOX15, ALOX5 | 3.74433 |
| [BP] GO:1903426 | None | EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 3.7324 |
| [BP] GO:0032101 | regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PPARG, SMAD3, TEK | 3.72991 |
| [BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, APP, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARG, SMAD3, SRC, TRPV1 | 3.72104 |
| [BP] GO:0031347 | regulation of defense response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, HSP90AB1, HSPA1A, MMP12, MMP2, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK | 3.71307 |
| [BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.69623 |
| [BP] GO:0042325 | regulation of phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH | 3.69153 |
| [BP] GO:0038083 | peptidyl-tyrosine autophosphorylation | EGFR, IGF1R, INSR, KDR, SRC | 3.68476 |
| [BP] GO:0031328 | positive regulation of cellular biosynthetic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, HSP90AA1, HSP90AB1, IGF1R, INSR, MET, MMP12, NR3C1, PPARA, PPARG, SMAD3, SRC, TNKS, TNKS2, TOP2A, TRPV1 | 3.67293 |
| [BP] GO:0009892 | negative regulation of metabolic process | ADORA1, APEX1, APP, AURKB, BCL2, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TRPV1, XDH | 3.66298 |
| [BP] GO:0080090 | regulation of primary metabolic process | ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.64953 |
| [BP] GO:0001666 | response to hypoxia | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK | 3.64842 |
| [BP] GO:0003006 | developmental process involved in reproduction | ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSP90AB1, INSR, PPARG, SRC | 3.62907 |
| [BP] GO:0034599 | cellular response to oxidative stress | AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.62395 |
| [BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CHRM5, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.61382 |
| [BP] GO:0010557 | positive regulation of macromolecule biosynthetic process | APP, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, MMP12, NR3C1, PPARA, PPARG, SMAD3, SRC, TNKS, TNKS2, TOP2A | 3.60862 |
| [BP] GO:0002682 | regulation of immune system process | ADORA1, ALOX15, APP, AXL, BCL2, CA2, CDK6, CYP19A1, DUSP3, ESR1, ESRRA, HCAR2, HSP90AA1, HSP90AB1, HSPA1A, MMP12, MMP2, PPARG, PTPN1, SMAD3, SRC | 3.60804 |
| [BP] GO:0032270 | positive regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HMGCR, HSP90AB1, HSPA1A, INSR, KDR, MMP9, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 3.59647 |
| [BP] GO:0043410 | positive regulation of MAPK cascade | ADORA1, ALOX15, APP, EGFR, FLT3, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH | 3.59355 |
| [BP] GO:0010648 | negative regulation of cell communication | ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SMAD3, SRC, XDH | 3.56042 |
| [BP] GO:0036293 | response to decreased oxygen levels | ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, SMAD3, SRC, TEK | 3.56042 |
| [BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, SRC | 3.56042 |
| [BP] GO:0009698 | phenylpropanoid metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.56042 |
| [BP] GO:0009804 | coumarin metabolic process | CYP1A1, CYP2A13, CYP2A6 | 3.56042 |
| [BP] GO:0095500 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.55023 |
| [BP] GO:1903831 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.55023 |
| [BP] GO:0023057 | negative regulation of signaling | ACHE, ADORA1, BCL2, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SMAD3, SRC, XDH | 3.54899 |
| [BP] GO:0010638 | positive regulation of organelle organization | ALOX15, AURKB, BCL2, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TNKS, TNKS2 | 3.53455 |
| [BP] GO:0048608 | reproductive structure development | AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSP90AB1, INSR, PPARG, SRC | 3.53455 |
| [BP] GO:0016042 | lipid catabolic process | ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 | 3.53455 |
| [BP] GO:0043408 | regulation of MAPK cascade | ADORA1, ALOX15, APP, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH | 3.52749 |
| [BP] GO:0043085 | positive regulation of catalytic activity | ADORA1, APP, AURKB, BCL2, CDC25B, EGFR, ESR1, F3, FLT3, HSP90AA1, HSP90AB1, HSPA1A, INSR, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, XDH | 3.52749 |
| [BP] GO:0010564 | regulation of cell cycle process | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, EGFR, HSP90AA1, HSP90AB1, HSPA1A, INSR, TNKS | 3.52352 |
| [BP] GO:0009991 | response to extracellular stimulus | ALPL, AXL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PPARG, SRC, TRPV1, TYR | 3.52352 |
| [BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK | 3.49239 |
| [BP] GO:0032845 | None | ADORA1, BCL2, HMGCR, SRC, TNKS, TNKS2, TRPV1 | 3.49239 |
| [BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.49239 |
| [BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, SRC | 3.49046 |
| [BP] GO:0017144 | drug metabolic process | ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, EGFR, HSPA1A | 3.48417 |
| [BP] GO:0001934 | positive regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, HMGCR, HSP90AB1, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.47266 |
| [BP] GO:0043436 | oxoacid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, PIM1, PPARA, PPARG, TYR | 3.46272 |
| [BP] GO:0043434 | None | APEX1, FABP3, HSD11B2, INSR, PPARA, PPARG, SRC, TEK, TRPV1 | 3.45354 |
| [BP] GO:0051896 | regulation of protein kinase B signaling | AXL, EGFR, F3, INSR, MET, SRC, TEK, XDH | 3.40829 |
| [BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, PPARG, SRC, TOP2A | 3.38239 |
| [BP] GO:0006082 | organic acid metabolic process | ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, GLO1, PIM1, PPARA, PPARG, TYR | 3.37331 |
| [BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, EGFR, F3, INSR, MET, SRC, TEK | 3.35459 |
| [BP] GO:0051128 | regulation of cellular component organization | ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, EGFR, ESR1, ESR2, HSP90AA1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 3.32027 |
| [BP] GO:0080135 | regulation of cellular response to stress | APP, CDK6, DUSP3, EGFR, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH | 3.31905 |
| [BP] GO:0045787 | positive regulation of cell cycle | APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSP90AB1, INSR, SRC | 3.31286 |
| [BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1, SRC | 3.31286 |
| [BP] GO:0003018 | None | ADORA1, CHRM1, CHRM3, EGFR, HMGCR, SRC, TEK | 3.31286 |
| [BP] GO:0007271 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.31286 |
| [BP] GO:0048545 | response to steroid hormone | ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, NR3C1, SRC | 3.31273 |
| [BP] GO:0072593 | reactive oxygen species metabolic process | ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR | 3.29464 |
| [BP] GO:0006950 | response to stress | ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, HSD11B2, HSP90AA1, HSP90AB1, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1 | 3.27702 |
| [BP] GO:0001952 | regulation of cell-matrix adhesion | BCL2, CDK6, KDR, SMAD3, SRC, TEK | 3.27335 |
| [BP] GO:0051701 | interaction with host | AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC | 3.26861 |
| [BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, SRC, TEK, TNKS, TOP2A | 3.24962 |
| [BP] GO:0031399 | regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH | 3.24795 |
| [BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG | 3.24068 |
| [BP] GO:1901617 | organic hydroxy compound biosynthetic process | AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HMGCR, TYR | 3.20843 |
| [BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR | 3.19357 |
| [BP] GO:0001932 | regulation of protein phosphorylation | ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 3.19193 |
| [BP] GO:0051052 | regulation of DNA metabolic process | AURKB, EGFR, HSP90AA1, HSP90AB1, IGF1R, INSR, PPARG, SRC, TNKS, TNKS2 | 3.17645 |
| [BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 3.17645 |
| [BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.17645 |
| [BP] GO:0019538 | protein metabolic process | ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, HSP90AA1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 3.13288 |
| [BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.12027 |
| [BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PPARG, SRC, TRPV1 | 3.11857 |
| [BP] GO:0031348 | negative regulation of defense response | ADORA1, CYP19A1, MMP12, PPARA, PPARG, SMAD3, TEK | 3.07485 |
| [BP] GO:0009894 | regulation of catabolic process | ADORA1, APEX1, BCL2, CSNK2A1, EGFR, ESRRB, HCAR2, HSP90AB1, HSPA1A, INSR, KDR, MET, PPARA, PTPN1, SMAD3 | 3.06396 |
| [BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, HSP90AB1 | 3.05507 |
| [BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 3.04026 |
| [BP] GO:0050728 | negative regulation of inflammatory response | ADORA1, CYP19A1, PPARA, PPARG, SMAD3, TEK | 3.03629 |
| [BP] GO:0031667 | response to nutrient levels | ALPL, BCL2, CYP1A1, EGFR, HMGCR, HSD11B2, PPARG, SRC, TRPV1, TYR | 3.0333 |
| [BP] GO:0071363 | cellular response to growth factor stimulus | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 3.00523 |
| [BP] GO:0010907 | None | ESRRB, INSR, PPARA, SRC | 3.00483 |
| [BP] GO:0042180 | None | AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR | 2.99387 |
| [BP] GO:1901654 | None | AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, PPARG, SRC | 2.97773 |
| [BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CYP1B1, F3, HCAR2, HMGCR, MMP9, PPARG, SMAD3, SRC, TOP2A, TRPV1, XDH | 2.95345 |
| [BP] GO:0050678 | None | CDK6, EGFR, F3, KDR, MMP12, PPARG, SMAD3, TEK, XDH | 2.93783 |
| [BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CYP1B1, F3, HCAR2, HMGCR, MMP9, PPARG, SMAD3, SRC, TOP2A, TRPV1, XDH | 2.91403 |
| [BP] GO:1903725 | regulation of phospholipid metabolic process | CHRM5, FABP3, FLT3, SRC, TEK | 2.91186 |
| [BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, EGFR, HSP90AA1, HSP90AB1, INSR, SMAD3, TRPV1 | 2.89279 |
| [BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH | 2.89203 |
| [BP] GO:0042738 | exogenous drug catabolic process | CYP1A2, CYP2A6, CYP3A4 | 2.89167 |
| [BP] GO:0045834 | positive regulation of lipid metabolic process | FABP3, FLT3, PPARA, PPARG, SRC, TEK | 2.8911 |
| [BP] GO:0051973 | positive regulation of telomerase activity | AURKB, HSP90AA1, HSP90AB1, TNKS | 2.87373 |
| [BP] GO:0009115 | None | AOX1, XDH | 2.87373 |
| [BP] GO:2001301 | lipoxin biosynthetic process | ALOX12, ALOX15 | 2.87373 |
| [BP] GO:2001302 | lipoxin A4 metabolic process | ALOX12, ALOX15 | 2.87373 |
| [BP] GO:2001303 | lipoxin A4 biosynthetic process | ALOX12, ALOX15 | 2.87373 |
| [BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PPARG, SRC, TRPV1 | 2.86064 |
| [BP] GO:0043405 | regulation of MAP kinase activity | ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC | 2.859 |
| [BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 2.8535 |
| [BP] GO:0010810 | regulation of cell-substrate adhesion | ALOX15, BCL2, CDK6, KDR, SMAD3, SRC, TEK | 2.8535 |
| [BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, KDR, MET, MMP2, MMP9, PPARG, SMAD3, SRC, TEK, TOP2A | 2.85082 |
| [BP] GO:0043549 | regulation of kinase activity | ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, PTPN1, SRC, TEK | 2.83104 |
| [BP] GO:0050793 | regulation of developmental process | ALOX12, APP, AXL, BCL2, CA2, CDK6, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, HMGCR, HSP90AB1, INSR, KDR, NUAK1, PIM1, PPARA, PPARG, SMAD3, SRC, TEK, TNKS2, TRPV1, XDH | 2.83 |
| [BP] GO:0007193 | None | ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 | 2.83 |
| [BP] GO:0031100 | animal organ regeneration | AXL, CSNK2A1, EGFR, FLT3, PPARG | 2.83 |
| [BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9 | 2.83 |
| [BP] GO:0009895 | negative regulation of catabolic process | ADORA1, BCL2, EGFR, HCAR2, HSP90AB1, MET, PPARA, SMAD3 | 2.82916 |
| [BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, EGFR, HMGCR, MMP2, MMP9, PPARG | 2.82261 |
| [BP] GO:0031324 | negative regulation of cellular metabolic process | APEX1, APP, AURKB, BCL2, CSNK2A1, DUSP3, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, HSPA1A, IGF1R, MET, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TRPV1, XDH | 2.82031 |
| [BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.81292 |
| [BP] GO:0007584 | response to nutrient | ALPL, CYP1A1, EGFR, HMGCR, PPARG, TRPV1, TYR | 2.79732 |
| [BP] GO:0051172 | None | APEX1, APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, HSPA1A, IGF1R, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TRPV1, XDH | 2.76586 |
| [BP] GO:0010605 | negative regulation of macromolecule metabolic process | APEX1, APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HMGCR, HSP90AB1, HSPA1A, IGF1R, KDR, MMP12, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TRPV1, XDH | 2.75467 |
| [BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, EGFR, HMGCR, KDR, SRC, TEK | 2.74487 |
| [BP] GO:0032268 | regulation of cellular protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 2.74487 |
| [BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.71986 |
| [BP] GO:1901655 | None | AKR1B1, EGFR, NR3C1, PPARG, SRC | 2.71232 |
| [BP] GO:0040008 | regulation of growth | ALOX12, APP, BCL2, CSNK2A1, EGFR, ESR2, HSPA1A, INSR, PIM1, PPARG, SMAD3, TNKS2 | 2.69695 |
| [BP] GO:0031099 | regeneration | AXL, BCL2, CSNK2A1, EGFR, FLT3, PPARG | 2.6918 |
| [BP] GO:0033273 | response to vitamin | ALPL, CYP1A1, EGFR, PPARG, TYR | 2.69155 |
| [BP] GO:0032102 | negative regulation of response to external stimulus | ADORA1, ALOX12, CYP19A1, HMGCR, PPARA, PPARG, SMAD3, TEK | 2.66925 |
| [BP] GO:0070848 | response to growth factor | APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 | 2.66925 |
| [BP] GO:0010942 | positive regulation of cell death | BCL2, CYP1B1, F3, HCAR2, HMGCR, MMP9, PPARG, SMAD3, SRC, TOP2A, TRPV1, XDH | 2.65429 |
| [BP] GO:0006352 | DNA-templated transcription, initiation | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG | 2.65209 |
| [BP] GO:0003013 | None | ADORA1, CHRM1, CHRM3, EGFR, HMGCR, SRC, TEK | 2.65209 |
| [BP] GO:0051094 | positive regulation of developmental process | ALOX12, APP, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, HMGCR, HSP90AB1, INSR, KDR, PIM1, PPARG, SMAD3, SRC, TEK | 2.65209 |
| [BP] GO:0032868 | None | FABP3, HSD11B2, INSR, PPARA, PPARG, SRC | 2.65209 |
| [BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, EGFR, FLT3, HSD11B2, NR3C1 | 2.65209 |
| [BP] GO:0002009 | morphogenesis of an epithelium | BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.64736 |
| [BP] GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | CSNK2A1, F3, MMP9, PPARG, SMAD3, SRC, XDH | 2.64506 |
| [BP] GO:1903727 | positive regulation of phospholipid metabolic process | FABP3, FLT3, SRC, TEK | 2.62315 |
| [BP] GO:1901653 | cellular response to peptide | AKR1B1, APEX1, APP, IGF1R, INSR, PPARG, SRC | 2.62315 |
| [BP] GO:2000021 | regulation of ion homeostasis | ADORA1, BCL2, CA2, CA7, KDR, SRC, TRPV1 | 2.62315 |
| [BP] GO:0030155 | regulation of cell adhesion | ALOX12, ALOX15, BCL2, CDK6, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK | 2.61946 |
| [BP] GO:0007200 | None | CHRM1, CHRM2, CHRM3, CHRM5, ESR1 | 2.5894 |
| [BP] GO:0043412 | macromolecule modification | ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, HSP90AA1, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.58103 |
| [BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, APP, CDC25B, CYP1A1, DUSP3, INSR | 2.5792 |
| [BP] GO:0045859 | regulation of protein kinase activity | ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, PTPN1, SRC | 2.57326 |
| [BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.57326 |
| [BP] GO:0051131 | None | HSP90AA1, HSP90AB1, HSPA1A | 2.57326 |
| [BP] GO:0019372 | lipoxygenase pathway | ALOX12, ALOX15, ALOX5 | 2.57326 |
| [BP] GO:0001954 | positive regulation of cell-matrix adhesion | CDK6, KDR, SMAD3, TEK | 2.55847 |
| [BP] GO:0014074 | response to purine-containing compound | APEX1, APP, PPARG, TEK, TRPV1, TYR | 2.55504 |
| [BP] GO:0032872 | regulation of stress-activated MAPK cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 2.54837 |
| [BP] GO:0051347 | positive regulation of transferase activity | ADORA1, AURKB, CDC25B, EGFR, FLT3, HSP90AA1, HSP90AB1, INSR, PTPN1, SRC, TEK, TNKS | 2.53906 |
| [BP] GO:0070302 | regulation of stress-activated protein kinase signaling cascade | APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH | 2.53906 |
| [BP] GO:0006464 | cellular protein modification process | ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.53771 |
| [BP] GO:0036211 | protein modification process | ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.53771 |
| [BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.53006 |
| [BP] GO:0044267 | cellular protein metabolic process | ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ESR1, FLT3, FUT7, HSP90AA1, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A | 2.52405 |
| [BP] GO:1904355 | positive regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.50634 |
| [BP] GO:0050727 | regulation of inflammatory response | ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, PPARG, SMAD3, TEK | 2.49561 |
| [BP] GO:0046110 | None | AOX1, XDH | 2.49067 |
| [BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.49067 |
| [BP] GO:0090087 | None | ACHE, ADORA1, APP, CA2, CHRM1, EGFR, HCAR2, HMGCR, HSP90AB1, MMP12, PTPN1, SMAD3, SRC | 2.47628 |
| [BP] GO:0009968 | negative regulation of signal transduction | BCL2, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARG, PTPN1, SMAD3, SRC, XDH | 2.4712 |
| [BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, HSPA1A, MMP9, PTPN1, SRC | 2.44372 |
| [BP] GO:0016137 | None | AKR1B1, AKR1B10, GBA2 | 2.44182 |
| [BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 | 2.43793 |
| [BP] GO:0006807 | nitrogen compound metabolic process | ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 2.43793 |
| [BP] GO:0065007 | biological regulation | ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, XDH | 2.39994 |
| [BP] GO:0031401 | positive regulation of protein modification process | ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, FLT3, HMGCR, HSP90AB1, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH | 2.37603 |
| [BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.37506 |
| [BP] GO:0071900 | regulation of protein serine/threonine kinase activity | ADORA1, DUSP3, EGFR, FLT3, HMGCR, HSP90AB1, IGF1R, INSR, PTPN1, SRC | 2.37332 |
| [BP] GO:0001775 | cell activation | ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSP90AA1, HSP90AB1, HSPA1A, MMP9, SMAD3, SRC, TRPV1 | 2.35018 |
| [BP] GO:0010676 | None | ESRRB, INSR, PPARA, SRC | 2.34826 |
| [BP] GO:2000116 | regulation of cysteine-type endopeptidase activity | CSNK2A1, F3, MMP9, PPARG, SMAD3, SRC, XDH | 2.33517 |
| [BP] GO:0051828 | entry into other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.33517 |
| [BP] GO:0030260 | entry into host cell | AXL, EGFR, HSPA1A, MET, SRC | 2.33517 |
| [BP] GO:0051806 | entry into cell of other organism involved in symbiotic interaction | AXL, EGFR, HSPA1A, MET, SRC | 2.33517 |
| [BP] GO:0044409 | entry into host | AXL, EGFR, HSPA1A, MET, SRC | 2.33517 |
| [BP] GO:0032210 | regulation of telomere maintenance via telomerase | AURKB, SRC, TNKS, TNKS2 | 2.32302 |
| [BP] GO:0001101 | response to acid chemical | AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PPARG, SRC | 2.30973 |
| [BP] GO:1904951 | positive regulation of establishment of protein localization | ACHE, APP, BCL2, CHRM1, EGFR, HCAR2, HSP90AB1, MMP12, SMAD3, SRC | 2.30146 |
| [BP] GO:0051893 | regulation of focal adhesion assembly | KDR, SMAD3, SRC, TEK | 2.29522 |
| [BP] GO:0090109 | regulation of cell-substrate junction assembly | KDR, SMAD3, SRC, TEK | 2.29522 |
| [BP] GO:0001959 | None | AXL, HSP90AB1, HSPA1A, MMP12, PPARG, PTPN1 | 2.28152 |
| [BP] GO:0044057 | None | ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, EGFR, GPR35, HCAR2, SMAD3, TRPV1 | 2.27899 |
| [BP] GO:0048732 | gland development | BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR | 2.27683 |
| [BP] GO:0044236 | multicellular organism metabolic process | MMP1, MMP12, MMP2, MMP9, TRPV1 | 2.24911 |
| [BP] GO:0010811 | positive regulation of cell-substrate adhesion | ALOX15, CDK6, KDR, SMAD3, TEK | 2.24911 |
| [BP] GO:0051704 | multi-organism process | APP, AXL, BCL2, CDK6, CHRM2, CYP1A1, EGFR, HSD11B2, HSP90AB1, HSPA1A, INSR, KDR, MET, MMP1, MMP12, SMAD3, SRC | 2.23584 |
| [BP] GO:1905323 | None | HSP90AA1, HSP90AB1 | 2.23479 |
| [BP] GO:0070213 | None | TNKS, TNKS2 | 2.23479 |
| [BP] GO:0006145 | None | AOX1, XDH | 2.23479 |
| [BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.23479 |
| [BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 | 2.22733 |
| [BP] GO:0051246 | regulation of protein metabolic process | ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PPARG, PTPN1, SMAD3, SRC, TEK, XDH | 2.22484 |
| [BP] GO:1903391 | regulation of adherens junction organization | KDR, SMAD3, SRC, TEK | 2.22474 |
| [BP] GO:0030520 | intracellular estrogen receptor signaling pathway | ESR1, ESR2, SRC | 2.21701 |
| [BP] GO:0009605 | response to external stimulus | ADORA1, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, EGFR, HMGCR, HSD11B2, MMP12, PPARG, SMAD3, SRC, TRPV1, TYR | 2.19512 |
| [BP] GO:0060759 | None | AXL, HSP90AB1, HSPA1A, MMP12, PPARG, PTPN1 | 2.19408 |
| [BP] GO:0034502 | protein localization to chromosome | AURKB, ESR1, TNKS, TNKS2 | 2.17347 |
| [BP] GO:0070988 | demethylation | APEX1, CYP1A1, CYP1A2, CYP3A4 | 2.17347 |
| [BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.16452 |
| [BP] GO:1901575 | None | ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, GBA2, HSP90AA1, HSPA1A, XDH | 2.15588 |
| [BP] GO:0032870 | cellular response to hormone stimulus | APEX1, EGFR, ESR1, FLT3, INSR, NR3C1, PPARG, SRC | 2.15565 |
| [BP] GO:1904356 | regulation of telomere maintenance via telomere lengthening | AURKB, SRC, TNKS, TNKS2 | 2.14883 |
| [BP] GO:1901987 | None | APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, EGFR, HSP90AA1 | 2.13291 |
| [BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.12275 |
| [BP] GO:0051894 | None | KDR, SMAD3, TEK | 2.11747 |
| [BP] GO:0035902 | response to immobilization stress | CYP1A1, CYP1A2, PPARG | 2.11747 |
| [BP] GO:0061900 | None | APP, EGFR, TRPV1 | 2.11747 |
| [BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1 | 2.11747 |
| [BP] GO:0002521 | leukocyte differentiation | AXL, BCL2, FLT3, FUT7, GLO1, MMP9, PPARG | 2.11007 |
| [BP] GO:0030336 | None | ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, PPARG | 2.07138 |
| [BP] GO:0050927 | None | F3, KDR, SMAD3 | 2.06711 |
| [BP] GO:0048871 | multicellular organismal homeostasis | ADORA1, AKR1B1, ALOX12, MET, TRPV1 | 2.06692 |
| [BP] GO:0048729 | tissue morphogenesis | BCL2, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC | 2.06692 |
| [BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, SMAD3, TRPV1 | 2.06323 |
| [BP] GO:0071396 | cellular response to lipid | AXL, CDK6, EGFR, ESR1, FLT3, NR3C1, PPARG, SRC | 2.06047 |
| [BP] GO:0046541 | None | CHRM1, CHRM3 | 2.05405 |
| [BP] GO:0043696 | None | CDK6, ESRRB | 2.05405 |
| [BP] GO:0043697 | None | CDK6, ESRRB | 2.05405 |
| [BP] GO:0010641 | None | F3, SRC | 2.05405 |
| [BP] GO:0032800 | receptor biosynthetic process | ACHE, PPARG | 2.05405 |
| [BP] GO:0051122 | hepoxilin biosynthetic process | ALOX12, ALOX15 | 2.05405 |
| [BP] GO:0051121 | hepoxilin metabolic process | ALOX12, ALOX15 | 2.05405 |
| [BP] GO:0010891 | None | PPARA, PPARG | 2.05405 |
| [BP] GO:0097237 | cellular response to toxic substance | AKR1B1, APEX1, AXL, CYP1B1, KDR | 2.04577 |
| [BP] GO:0008150 | biological_process | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 2.04511 |
| [BP] GO:0046903 | None | ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, HSP90AA1, HSP90AB1, HSPA1A, MMP9, TRPV1, XDH | 2.0433 |
| [BP] GO:0030574 | collagen catabolic process | MMP1, MMP12, MMP2, MMP9 | 2.0433 |
| [BP] GO:0006940 | None | ADORA1, CHRM1, CHRM2, CHRM3 | 2.0433 |
| [BP] GO:0006706 | steroid catabolic process | CYP19A1, CYP1A2, CYP3A4 | 2.03894 |
| [BP] GO:0050926 | None | F3, KDR, SMAD3 | 2.03894 |
| [BP] GO:1904353 | regulation of telomere capping | AURKB, TNKS, TNKS2 | 2.03894 |
| [BP] GO:1903393 | None | KDR, SMAD3, TEK | 2.03894 |
| [BP] GO:0050806 | positive regulation of synaptic transmission | ADORA1, APP, CA2, CA7, EGFR | 2.03879 |
| [CC] GO:0016323 | basolateral plasma membrane | ADORA1, CA2, CA4, CA9, CHRM3, EGFR, HSP90AB1, TEK | 3.72908 |
| [CC] GO:0044444 | cytoplasmic part | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, INSR, KDR, MMP2, MMP9, NR3C1, PIM1, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 3.68795 |
| [CC] GO:0016020 | membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GLO1, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TRPV1, TYR | 3.45354 |
| [CC] GO:0098590 | plasma membrane region | ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, HSP90AA1, HSP90AB1, INSR, MET, SRC, TEK, TRPV1 | 3.31286 |
| [CC] GO:0005886 | plasma membrane | ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, EGFR, ESR1, F3, FLT3, GBA2, GLO1, GPR35, HCAR2, HSP90AA1, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1 | 3.02749 |
| [CC] GO:0044432 | endoplasmic reticulum part | APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1 | 2.55735 |
| [CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2 | 2.52672 |
| [CC] GO:0044425 | membrane part | ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GBA2, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK, TRPV1, TYR | 2.50256 |
| [CC] GO:0031226 | intrinsic component of plasma membrane | ADORA1, ADORA3, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 | 2.4241 |
| [CC] GO:0031253 | None | ADORA1, CA4, CA9, HSP90AA1, HSP90AB1, INSR, SRC, TRPV1 | 2.36549 |
| [CC] GO:0043227 | membrane-bounded organelle | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TNKS, TNKS2, TOP2A, TYR, XDH | 2.34315 |
| [CC] GO:0044459 | plasma membrane part | ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DUSP3, EGFR, F3, FLT3, GPR35, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MET, SRC, TEK, TRPV1 | 2.27136 |
| [CC] GO:0048471 | perinuclear region of cytoplasm | ACHE, AKR1B1, APEX1, APP, CA4, EGFR, HSPA1A, PPARG, SRC, TNKS2, TYR | 2.17634 |
| [CC] GO:0045202 | None | ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR | 2.11747 |
| [MF] GO:0046914 | transition metal ion binding | ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PPARG, PTPN1, SMAD3, TNKS, TYR, XDH | 21.3711 |
| [MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 16.2426 |
| [MF] GO:0003824 | catalytic activity | ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, TNKS, TNKS2, TOP2A, TYR, XDH | 15.7394 |
| [MF] GO:0043167 | ion binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 14.9472 |
| [MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.3393 |
| [MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 | 10.1914 |
| [MF] GO:0008270 | zinc ion binding | CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA, PPARG, PTPN1, SMAD3, TNKS | 10.0128 |
| [MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH | 9.25291 |
| [MF] GO:0043169 | cation binding | ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 9.01088 |
| [MF] GO:0008144 | drug binding | ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, EGFR, FLT3, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, PPARG, SRC, TEK, TOP2A, TRPV1 | 8.55325 |
| [MF] GO:0005506 | iron ion binding | ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH | 8.4259 |
| [MF] GO:0046872 | metal ion binding | ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 8.12493 |
| [MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 | 8.03289 |
| [MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 | 7.75592 |
| [MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.88977 |
| [MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 6.72744 |
| [MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 6.64065 |
| [MF] GO:0038023 | signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PPARG, TEK, TRPV1 | 6.55934 |
| [MF] GO:0016907 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 6.24591 |
| [MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK | 6.18216 |
| [MF] GO:0060089 | molecular transducer activity | ADORA1, ADORA3, AXL, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PPARG, TEK, TRPV1 | 6.01322 |
| [MF] GO:0005496 | steroid binding | CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1 | 5.92937 |
| [MF] GO:0003707 | steroid hormone receptor activity | ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, PPARG | 5.72845 |
| [MF] GO:0004713 | protein tyrosine kinase activity | AXL, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, SRC, TEK | 5.72845 |
| [MF] GO:0004872 | receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PPARG, TEK, TRPV1 | 5.66552 |
| [MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR | 5.64735 |
| [MF] GO:0030235 | nitric-oxide synthase regulator activity | EGFR, ESR1, HSP90AA1, HSP90AB1 | 5.56727 |
| [MF] GO:0004871 | signal transducer activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, PPARG, SMAD3, TEK, TRPV1 | 5.52725 |
| [MF] GO:0008289 | lipid binding | ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, PPARA, PPARG, TRPV1 | 5.11665 |
| [MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 | 5.09038 |
| [MF] GO:0044877 | macromolecular complex binding | ACHE, ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC | 5.03309 |
| [MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.00123 |
| [MF] GO:0032403 | protein complex binding | ACHE, ADORA1, APEX1, EGFR, ESRRB, FLT3, HSP90AA1, HSP90AB1, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC | 4.95857 |
| [MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG | 4.89225 |
| [MF] GO:0004879 | nuclear receptor activity | ESR1, ESR2, ESRRA, ESRRB, PPARA, PPARG | 4.89225 |
| [MF] GO:0042562 | hormone binding | ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR, NR3C1 | 4.80141 |
| [MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC | 4.79682 |
| [MF] GO:0019899 | enzyme binding | APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HMGCR, HSP90AA1, HSP90AB1, HSPA1A, MET, NR3C1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS2, TOP2A | 4.72482 |
| [MF] GO:0004672 | protein kinase activity | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 4.59503 |
| [MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC | 4.5825 |
| [MF] GO:0048037 | cofactor binding | AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HMGCR, HSD11B2, HSD17B1, SRC, XDH | 4.533 |
| [MF] GO:0008395 | steroid hydroxylase activity | CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 | 4.29265 |
| [MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR | 4.24524 |
| [MF] GO:0019902 | phosphatase binding | BCL2, EGFR, HMGCR, MET, PPARA, PPARG, PTPN1, SMAD3 | 4.07467 |
| [MF] GO:0015464 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 3.91201 |
| [MF] GO:0036094 | small molecule binding | ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARG, SRC, TEK, TOP2A, TRPV1, XDH | 3.87764 |
| [MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.72908 |
| [MF] GO:0042802 | identical protein binding | ACHE, AOX1, APP, BCL2, CSNK2A1, EGFR, ESR1, ESR2, FLT3, HMGCR, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, PPARG, SMAD3, TOP2A, TRPV1, TYR, XDH | 3.72908 |
| [MF] GO:0099600 | transmembrane receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARG, TEK, TRPV1 | 3.68927 |
| [MF] GO:0004888 | transmembrane signaling receptor activity | ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, PPARG, TEK, TRPV1 | 3.68927 |
| [MF] GO:0016301 | kinase activity | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 3.34804 |
| [MF] GO:0043168 | anion binding | ALOX15, AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARG, SRC, TEK, TOP2A, TRPV1, XDH | 3.33641 |
| [MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.31286 |
| [MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.25182 |
| [MF] GO:0004716 | signal transducer, downstream of receptor, with protein tyrosine kinase activity | EGFR, INSR, KDR | 3.25182 |
| [MF] GO:0031072 | heat shock protein binding | ADORA1, CSNK2A1, HSP90AB1, HSPA1A, KDR, NR3C1 | 3.23618 |
| [MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.20512 |
| [MF] GO:0004629 | None | ADORA1, CHRM1, CHRM3, CHRM5 | 3.15369 |
| [MF] GO:0000166 | nucleotide binding | AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH | 3.12027 |
| [MF] GO:1901265 | nucleoside phosphate binding | AOX1, AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HMGCR, HSD11B2, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1, XDH | 3.11857 |
| [MF] GO:0019903 | protein phosphatase binding | BCL2, EGFR, HMGCR, MET, PPARG, PTPN1 | 2.98106 |
| [MF] GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding | ESR1, ESR2 | 2.87373 |
| [MF] GO:0047977 | hepoxilin-epoxide hydrolase activity | ALOX12, ALOX15 | 2.87373 |
| [MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.87373 |
| [MF] GO:0008389 | None | CYP2A13, CYP2A6 | 2.87373 |
| [MF] GO:0005524 | ATP binding | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 | 2.85082 |
| [MF] GO:0099528 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.80536 |
| [MF] GO:0032559 | adenyl ribonucleotide binding | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 | 2.73123 |
| [MF] GO:0030554 | adenyl nucleotide binding | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TOP2A, TRPV1 | 2.69678 |
| [MF] GO:0019900 | None | AURKB, CDC25B, DUSP3, EGFR, ESR1, HSP90AA1, HSP90AB1, NR3C1, PTPN1, SMAD3, SRC, TOP2A | 2.66583 |
| [MF] GO:0042578 | None | ADORA1, ALPL, APEX1, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 | 2.65209 |
| [MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CDK6, CSNK2A1, EGFR, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK | 2.64506 |
| [MF] GO:0016903 | None | AKR1B1, AKR1B10, AOX1, XDH | 2.58803 |
| [MF] GO:0035258 | None | ESR1, FLT3, PPARG, SMAD3, SRC | 2.57326 |
| [MF] GO:0019901 | None | CDC25B, DUSP3, EGFR, ESR1, HSP90AA1, HSP90AB1, NR3C1, PTPN1, SMAD3, SRC, TOP2A | 2.53906 |
| [MF] GO:0008081 | None | ADORA1, APEX1, CHRM1, CHRM3, CHRM5 | 2.51986 |
| [MF] GO:1901363 | heterocyclic compound binding | ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH | 2.49067 |
| [MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.49067 |
| [MF] GO:0004052 | arachidonate 12-lipoxygenase activity | ALOX12, ALOX15 | 2.49067 |
| [MF] GO:0051120 | hepoxilin A3 synthase activity | ALOX12, ALOX15 | 2.49067 |
| [MF] GO:0097159 | organic cyclic compound binding | ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP12, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH | 2.29106 |
| [MF] GO:0001047 | None | ESR1, ESR2, ESRRB, MMP12, NR3C1, PPARG | 2.27136 |
| [MF] GO:0034056 | estrogen response element binding | ESR1, ESR2 | 2.23479 |
| [MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.23479 |
| [MF] GO:0051425 | None | APP, INSR | 2.23479 |
| [MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.23479 |
| [MF] GO:0008227 | None | CHRM1, CHRM2, CHRM3, CHRM5 | 2.22474 |
| [MF] GO:0009055 | electron transfer activity | AKR1B1, AOX1, CYP19A1, CYP1A2, XDH | 2.22474 |
| [MF] GO:0016788 | None | ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 | 2.21132 |
| [MF] GO:0005518 | collagen binding | ACHE, MMP12, MMP9, SMAD3 | 2.07487 |
| [MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.05405 |
| [MF] GO:0030284 | estrogen receptor activity | ESR1, ESR2 | 2.05405 |
| [MF] GO:0043559 | insulin binding | IGF1R, INSR | 2.05405 |
| [MF] GO:0003674 | molecular_function | ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPR35, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSP90AA1, HSP90AB1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PPARG, PTPN1, SMAD3, SRC, TEK, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH | 2.04511 |
| [MF] GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | ALOX12, ALOX15, ALOX5 | 2.03894 |
| [MF] GO:0140096 | catalytic activity, acting on a protein | AURKB, AXL, CDC25B, CDK6, CSNK2A1, DUSP3, EGFR, F3, FLT3, HSP90AA1, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK | 2.03329 |
| KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|
| Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA5B, CA5A, CA2, CA4, CA7, CA6, CA9, CA14 | 17.429 |
| Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, INSR, HSD17B1, HSD17B2, CYP1A1, CYP1B1, CYP19A1, IGF1R | 8.6949 |
| Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 9.6405 |
| Estrogen signaling pathway_Homo sapiens_hsa04915 | HSP90AA1, HSP90AB1, SRC, MMP2, MMP9, ESR1, EGFR, ESR2, HSPA1A | 7.7926 |
| Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 7.5839 |
| Adherens junction_Homo sapiens_hsa04520 | PTPN1, SMAD3, CSNK2A1, SRC, INSR, MET, EGFR, IGF1R | 7.5839 |
| Pathways in cancer_Homo sapiens_hsa05200 | HSP90AA1, SMAD3, HSP90AB1, FLT3, MMP1, MMP2, MMP9, EGFR, IGF1R, CDK6, BCL2, PPARG, MET | 6.5536 |
| PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | CHRM2, HSP90AA1, CDK6, HSP90AB1, CHRM1, INSR, KDR, BCL2, TEK, MET, EGFR, IGF1R | 6.3707 |
| Metabolic pathways_Homo sapiens_hsa01100 | CBR1, ALOX15, AKR1B1, ALOX12, HMGCR, TYR, CYP3A4, GBA2, CYP19A1, HSD11B1, CYP2A6, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, AOX1, ALPL, XDH | 6.171 |
| Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CBR1, CYP2A6, CYP2A13, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 7.289 |
| Proteoglycans in cancer_Homo sapiens_hsa05205 | SRC, MMP2, KDR, MMP9, MET, ESR1, EGFR, IGF1R | 4.4985 |
| Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | CHRM2, CHRM3, CHRM1, GPR35, ADORA3, CHRM5, ADORA1, TRPV1, NR3C1 | 4.4782 |
| Cholinergic synapse_Homo sapiens_hsa04725 | CHRM2, ACHE, CHRM3, CHRM1, CHRM5, BCL2 | 4.0659 |
| Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9, EGFR | 4.9481 |
| Rap1 signaling pathway_Homo sapiens_hsa04015 | SRC, INSR, KDR, TEK, MET, EGFR, IGF1R | 3.5423 |
| Retinol metabolism_Homo sapiens_hsa00830 | CYP2A6, CYP1A2, CYP1A1, AOX1, CYP3A4 | 4.0659 |
| MicroRNAs in cancer_Homo sapiens_hsa05206 | CDK6, BCL2, PIM1, CYP1B1, MMP9, MET, EGFR, CDC25B | 3.5071 |
| Prostate cancer_Homo sapiens_hsa05215 | HSP90AA1, HSP90AB1, BCL2, EGFR, IGF1R | 3.5071 |
| AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | SMAD3, MMP2, BCL2, PIM1, F3 | 3.275 |
| PPAR signaling pathway_Homo sapiens_hsa03320 | FABP3, FABP4, MMP1, PPARG, PPARA | 3.9642 |
| Endocytosis_Homo sapiens_hsa04144 | SMAD3, SRC, KDR, MET, EGFR, IGF1R, HSPA1A | 3.0844 |
| HIF-1 signaling pathway_Homo sapiens_hsa04066 | INSR, BCL2, TEK, EGFR, IGF1R | 3.2538 |
| Tryptophan metabolism_Homo sapiens_hsa00380 | CYP1A2, CYP1A1, AOX1, CYP1B1 | 3.6492 |
| Focal adhesion_Homo sapiens_hsa04510 | SRC, KDR, BCL2, MET, EGFR, IGF1R | 2.8639 |
| Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | CHRM2, CHRM3, CHRM1, SRC, CHRM5, EGFR | 2.7752 |
| Ras signaling pathway_Homo sapiens_hsa04014 | INSR, KDR, TEK, MET, EGFR, IGF1R | 2.667 |
| Hepatitis B_Homo sapiens_hsa05161 | CDK6, SMAD3, SRC, BCL2, MMP9 | 2.6757 |
| Arachidonic acid metabolism_Homo sapiens_hsa00590 | CBR1, ALOX5, ALOX15, ALOX12 | 3.0375 |
| Melanoma_Homo sapiens_hsa05218 | CDK6, MET, EGFR, IGF1R | 2.8586 |
| Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | CYP2A6, CYP1A2, AOX1, CYP3A4 | 2.8742 |
| Calcium signaling pathway_Homo sapiens_hsa04020 | CHRM2, CHRM3, CHRM1, CHRM5, EGFR | 2.3298 |
| Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | HSP90AA1, HSP90AB1, CDC25B, IGF1R | 2.3978 |
| Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, PPARG, MMP9, MET, IGF1R | 2.3298 |
| cAMP signaling pathway_Homo sapiens_hsa04024 | CHRM2, HCAR2, CHRM1, ADORA1, PPARA | 2.1606 |
| Serotonergic synapse_Homo sapiens_hsa04726 | APP, ALOX5, ALOX15, ALOX12 | 2.232 |
| AMPK signaling pathway_Homo sapiens_hsa04152 | INSR, PPARG, HMGCR, IGF1R | 2.1036 |
| FoxO signaling pathway_Homo sapiens_hsa04068 | SMAD3, INSR, EGFR, IGF1R | 2.0074 |
| Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | HSP90AA1, HSP90AB1, BCL2, HSPA1A | 1.7289 |
| Glioma_Homo sapiens_hsa05214 | CDK6, EGFR, IGF1R | 1.9983 |
| Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, INSR, ADORA1 | 2.1414 |
| Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | INSR, IGF1R, HSPA1A | 2.0074 |
| Pancreatic cancer_Homo sapiens_hsa05212 | CDK6, SMAD3, EGFR | 1.9897 |
| GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, EGFR | 1.6714 |
| Central carbon metabolism in cancer_Homo sapiens_hsa05230 | FLT3, MET, EGFR | 1.9809 |
| Prolactin signaling pathway_Homo sapiens_hsa04917 | SRC, ESR1, ESR2 | 1.9205 |
| Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | SRC, ALOX12, TRPV1 | 1.6153 |
| Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | INSR, PPARG, IGF1R | 1.6492 |
| Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET, EGFR | 1.9718 |
| Insulin resistance_Homo sapiens_hsa04931 | PTPN1, INSR, PPARA | 1.5127 |
| Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP2A6, CYP3A4, XDH | 2.3299 |
| Bile secretion_Homo sapiens_hsa04976 | CA2, HMGCR, CYP3A4 | 1.9281 |
| MAPK signaling pathway_Homo sapiens_hsa04010 | DUSP3, EGFR, CDC25B, HSPA1A | 1.2474 |
| Toxoplasmosis_Homo sapiens_hsa05145 | ALOX5, BCL2, HSPA1A | 1.4349 |
| Measles_Homo sapiens_hsa05162 | CDK6, CSNK2A1, HSPA1A | 1.293 |
| Antigen processing and presentation_Homo sapiens_hsa04612 | HSP90AA1, HSP90AB1, HSPA1A | 1.856 |
| Sphingolipid signaling pathway_Homo sapiens_hsa04071 | ADORA3, BCL2, ADORA1 | 1.4224 |
| Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | SMAD3, ESRRB, IGF1R | 1.251 |
| Cell cycle_Homo sapiens_hsa04110 | CDK6, SMAD3, CDC25B | 1.3916 |
| Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KDR, MET, EGFR | 1.2253 |
| Jak-STAT signaling pathway_Homo sapiens_hsa04630 | BCL2, PIM1, AOX1 | 1.1942 |
| cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | ADORA3, INSR, ADORA1 | 1.1392 |
| Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, BCL2, HSPA1A | 0.9739 |
| HTLV-I infection_Homo sapiens_hsa05166 | SMAD3 | 0.1717 |
| Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 2.8564 |
| Huntington's disease_Homo sapiens_hsa05016 | PPARG | 0.244 |
| Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2503 |
| Purine metabolism_Homo sapiens_hsa00230 | XDH | 0.2619 |
| Chemokine signaling pathway_Homo sapiens_hsa04062 | SRC | 0.2501 |
| Influenza A_Homo sapiens_hsa05164 | HSPA1A | 0.2619 |
| Alzheimer's disease_Homo sapiens_hsa05010 | APP | 0.2698 |
| Hepatitis C_Homo sapiens_hsa05160 | PPARA, EGFR | 0.7354 |
| Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, INSR | 0.7219 |
| Wnt signaling pathway_Homo sapiens_hsa04310 | SMAD3, CSNK2A1 | 0.7138 |
| Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | SRC, ESR1 | 0.8035 |
| Hippo signaling pathway_Homo sapiens_hsa04390 | SMAD3 | 0.2952 |
| Leukocyte transendothelial migration_Homo sapiens_hsa04670 | MMP2, MMP9 | 0.8035 |
| Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC | 0.7219 |
| Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | BCL2 | 0.3025 |
| Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | INSR, PPARA | 0.6851 |
| Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.5892 |
| ErbB signaling pathway_Homo sapiens_hsa04012 | SRC, EGFR | 0.9825 |
| Phospholipase D signaling pathway_Homo sapiens_hsa04072 | INSR, EGFR | 0.71 |
| Apoptosis_Homo sapiens_hsa04210 | BCL2 | 0.317 |
| Spliceosome_Homo sapiens_hsa03040 | HSPA1A | 0.328 |
| Viral carcinogenesis_Homo sapiens_hsa05203 | CDK6, SRC | 0.5318 |
| Oxytocin signaling pathway_Homo sapiens_hsa04921 | SRC, EGFR | 0.6619 |
| Osteoclast differentiation_Homo sapiens_hsa04380 | PPARG | 0.3298 |
| Platelet activation_Homo sapiens_hsa04611 | SRC | 0.3469 |
| Axon guidance_Homo sapiens_hsa04360 | MET | 0.3394 |
| Neurotrophin signaling pathway_Homo sapiens_hsa04722 | BCL2 | 0.349 |
| Oocyte meiosis_Homo sapiens_hsa04114 | IGF1R | 0.3469 |
| Small cell lung cancer_Homo sapiens_hsa05222 | CDK6, BCL2 | 0.9863 |
| Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1, TEK | 0.9722 |
| Gap junction_Homo sapiens_hsa04540 | SRC, EGFR | 0.9792 |
| Pancreatic secretion_Homo sapiens_hsa04972 | CHRM3, CA2 | 0.9382 |
| TNF signaling pathway_Homo sapiens_hsa04668 | MMP9 | 0.3752 |
| Chronic myeloid leukemia_Homo sapiens_hsa05220 | CDK6, SMAD3 | 1.0973 |
| NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2 | 0.9574 |
| Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | SMAD3 | 0.3913 |
| Melanogenesis_Homo sapiens_hsa04916 | TYR | 0.3983 |
| Choline metabolism in cancer_Homo sapiens_hsa05231 | EGFR | 0.3983 |
| Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.3983 |
| Gastric acid secretion_Homo sapiens_hsa04971 | CHRM3, CA2 | 1.0923 |
| Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | SRC, MET | 1.0565 |
| Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4102 |
| Morphine addiction_Homo sapiens_hsa05032 | ADORA1 | 0.4222 |
| Taste transduction_Homo sapiens_hsa04742 | CHRM3 | 0.4318 |
| Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3 | 0.4268 |
| GABAergic synapse_Homo sapiens_hsa04727 | SRC | 0.4268 |
| TGF-beta signaling pathway_Homo sapiens_hsa04350 | SMAD3 | 0.4309 |
| Salivary secretion_Homo sapiens_hsa04970 | CHRM3 | 0.4268 |
| Insulin secretion_Homo sapiens_hsa04911 | CHRM3 | 0.43 |
| Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4268 |
| Peroxisome_Homo sapiens_hsa04146 | XDH | 0.4318 |
| Non-small cell lung cancer_Homo sapiens_hsa05223 | CDK6, EGFR | 1.2474 |
| Acute myeloid leukemia_Homo sapiens_hsa05221 | FLT3, PIM1 | 1.2472 |
| VEGF signaling pathway_Homo sapiens_hsa04370 | SRC, KDR | 1.217 |
| Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4429 |
| Colorectal cancer_Homo sapiens_hsa05210 | SMAD3, BCL2 | 1.2099 |
| Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.484 |
| NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | HSP90AA1, HSP90AB1 | 1.2472 |
| p53 signaling pathway_Homo sapiens_hsa04115 | CDK6 | 0.4859 |
| Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.2318 |
| Renal cell carcinoma_Homo sapiens_hsa05211 | MET | 0.4989 |
| Renin secretion_Homo sapiens_hsa04924 | ADORA1 | 0.5011 |
| Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5011 |
| Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | SMAD3 | 0.5011 |
| Long-term depression_Homo sapiens_hsa04730 | IGF1R | 0.5206 |
| Legionellosis_Homo sapiens_hsa05134 | HSPA1A | 0.5465 |
| Endometrial cancer_Homo sapiens_hsa05213 | EGFR | 0.5645 |
| Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | BCL2 | 0.5682 |
| Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, INSR | 1.4981 |
| Malaria_Homo sapiens_hsa05144 | MET | 0.5799 |
| Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | ESR1 | 0.5845 |
| Type II diabetes mellitus_Homo sapiens_hsa04930 | INSR | 0.5842 |
| Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | AOX1 | 0.5842 |
| Sphingolipid metabolism_Homo sapiens_hsa00600 | GBA2 | 0.5845 |
| Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.6647 |
| Tyrosine metabolism_Homo sapiens_hsa00350 | AOX1, TYR | 1.5664 |
| Prion diseases_Homo sapiens_hsa05020 | HSPA1A | 0.6815 |
| Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6364 |
| Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6262 |
| Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.5502 |
| Thyroid cancer_Homo sapiens_hsa05216 | PPARG | 0.7233 |
| Dorso-ventral axis formation_Homo sapiens_hsa04320 | EGFR | 0.739 |
| Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7138 |
| Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.697 |
| Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | AOX1 | 0.7233 |
| Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.8576 |
| Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.7452 |
| Caffeine metabolism_Homo sapiens_hsa00232 | CYP2A6, CYP1A2, XDH | 4.9658 |
| Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.739 |
| Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | HMGCR | 0.8035 |
| Other glycan degradation_Homo sapiens_hsa00511 | GBA2 | 0.8781 |
| Folate biosynthesis_Homo sapiens_hsa00790 | ALPL | 0.9686 |
| Vitamin B6 metabolism_Homo sapiens_hsa00750 | AOX1 | 1.245 |